L. Harrison

A Randomized, Double-Blinded, Placebo-Controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor (rhuLIF, Emfilermin, AM424) to Prevent Chemotherapy-Induced Peripheral Neuropathy

J. Arezzo, M. Quinn, L. Kiers, 2005, Clinical Cancer Research.

A Randomized , Double-Blinded , Placebo-Controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor ( rhuLIF , Emfilermin , AM 424 ) to Prevent Chemotherapy-Induced Peripheral Neuropathy

J. Arezzo, M. Quinn, L. Kiers, 2005 .

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis

M. Stein, T. Kilpatrick, H. Butzkueven, 2011, Neurology.